Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation

Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation

Advances in haploidentical bone marrow transplantation (h-BMT) have drastically broadened the treatment options for patients requiring BMT. The possibility of significantly reducing the complications resulting from graft-versus-host disease (GvHD) with the administration of post-transplant cyclophos...

Full description

Bibliographic Details
Main Authors: Stokes, Jessica, Hoffman, Emely A., Zeng, Yi, Larmonier, Nicolas, Katsanis, Emmanuel
Other Authors: University of Arizona
Language:en
Published: WILEY-BLACKWELL 2016
Subjects:
bone marrow transplantation
graft-versus-host disease
graft-versus-leukaemia
bendamustine
cyclophosphamide
Online Access:http://hdl.handle.net/10150/621784
http://arizona.openrepository.com/arizona/handle/10150/621784

Internet

http://hdl.handle.net/10150/621784
http://arizona.openrepository.com/arizona/handle/10150/621784

Similar Items